About Asper Biotech
Asper Biotech is a company based in Tartu (Estonia) founded in 1999. It operates as a B2B. Asper Biotech offers products and services including NGS Panels, Whole Exome Sequencing, and Whole Genome Sequencing. Asper Biotech operates in a competitive market with competitors including Foundation Medicine, Personalis, Omniome, Novogene Corporation and Tessera Therapeutics, among others.
- Headquarter Tartu, Estonia
- SectorsHealthcare
- Website asperbio.com
- Social LinkedIn X Facebook
- Legal Name Oü Asper Biolab
Products & Services of Asper Biotech
Asper Biotech offers a comprehensive portfolio of products and services, including NGS Panels, Whole Exome Sequencing, and Whole Genome Sequencing.
Sequencing panels for diagnosing hereditary disorders like metabolic diseases.
Comprehensive exome sequencing for identifying genetic mutations.
Full genome analysis for rare disease detection and research.
Competitors of Asper Biotech
Asper Biotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Foundation Medicine, Personalis, Omniome, Novogene Corporation and Tessera Therapeutics, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| foundationmedicine.com | 2010 | Cambridge, United States | $96.5M | 1,707 | Genomics-based diagnostic tests for cancer are provided. | |
| personalis.com | 2011 | Menlo Park, United States | $87.3M | 310 | Genomic sequencing and diagnosis software is provided for healthcare. | |
| omniome.com | 2013 | San Diego, United States | $160.23M | 164 | Genome sequencing platform is provided for clinical diagnostics. | |
| novogene.com | 2011 | Beijing, China | $75M | 141 | Genomic services and solutions with NGS expertise are provided. | |
| tesseratherapeutics.com | 2017 | Cambridge, United States | $610M | 149 | New genome engineering technology is provided for treating multiple diseases. | |
| lanternpharma.com | 2013 | Dallas, United States | $7.12M | 23 | Drug and companion diagnostics for multi-drug resistant cancers are developed. | |
| phasegenomics.com | 2015 | Seattle, United States | $5.75M | 19 | Laboratory and computational services for DNA proximity analysis are provided. | |
| medgenome.com | 2013 | Bengaluru, India | $264.5M | 922 | DNA sequencing, bioinformatics, and multiomics services are provided. | |
| brbiotech.com | 2014 | Guangzhou, China | $203.32M | – | Personalized cancer diagnostics are developed using genomic big data analysis. | |
| newhorizonbio.com | 2013 | Beijing, China | $151.83M | – | Provider of early cancer screening and testing services |
Detailed competitors of Asper Biotech
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Asper Biotech
Websites that share an audience with Asper Biotech (asperbio.com).
Websites whose visitors overlap most with Asper Biotech. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| preanalytix.com | 84% | 2.2K | #7,866,466 | View details |
Latest news on Asper Biotech
Complete news archive for Asper Biotech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Asper Biotech
10 companies that operate in the same segment as Asper Biotech (Clinical Genomics), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
CAR T-cell and T-cell receptor immunotherapies for cancer are developed. | 2013 | Seattle, Washington, United States | USD 316.67 M | – | 520 | |
Panomic profiling technologies are developed for cancer precision medicine. | 1996 | Irving, Texas, United States | USD 1.23 B | – | 1,339 | |
Genomics-based diagnostic tests for cancer are provided. | 2010 | Cambridge, Massachusetts, United States | USD 96.5 M | – | – | |
Digital molecular biology analytics are developed for disease management. | 2012 | Carlsbad, California, United States | USD 95.02 M | – | 46 | |
Diagnostic tests for cancer prognosis are provided. | 2008 | Friendswood, Texas, United States | USD 61.97 M | USD 344.23 M | 761 | |
Genomic database for clinical research is provided. | 2015 | San Francisco, California, United States | USD 435 M | – | – | |
Genomic sequencing and diagnosis software is provided for healthcare. | 2011 | Menlo Park, California, United States | USD 87.3 M | USD 69.65 M | 229 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Asper Biotech
Asper Biotech was founded in 1999.
Asper Biotech is headquartered in Tartu, Estonia.
Asper Biogene is a genetic testing company based in Tartu, Estonia, specializing in efficient DNA tests and next-generation sequencing panels for conditions like metabolic disorders, neurogenetics, and oncology. They deliver services through online ordering and submission forms, focusing on accurate diagnosis for healthcare providers and individuals worldwide. The company updates its portfolios regularly to include new tests for diseases such as Ehlers-Danlos syndrome and mitochondrial disorders, ensuring reliable genetic analysis.
Asper Biotech's top competitors include Foundation Medicine, MedGenome and Personalis.
Asper Biotech offers NGS Panels, Whole Exome Sequencing, and Whole Genome Sequencing.
Asper Biotech operates through Oü Asper Biolab.